A Guide to DEA Administrative Actions & Hearings
Created on February 23, 2017
The Drug Enforcement Administration (DEA) regulates the registration of manufacturers, distributors, pharmacies, and practitioners authorized to handle prescription drug controlled substances. The revocation of an existing registration, or the denial of an application for registration, can significantly impact the livelihood or business of an affected party. Under the Controlled Substances Act (CSA), such parties are entitled to a full administrative hearing before DEA’s administrative law judges.
Revocation and denial hearings are complex, and require detailed knowledge of DEA hearing procedures, as well as agency interpretation of the CSA and the DEA’s implementing regulations. This course, presented by Karla Palmer and Andrew Hull of Hyman, Phelps & McNamara P.C., provides an overview of the hearing process, an introduction to the statutory basis for revocation or denial, and a discussion of recent “hot” issues in DEA administrative decisions.
- Understand the basics of the DEA’s hearing process and procedures
- Know where and how to find relevant statutory and regulatory provisions, as well as agency precedent contained in prior decisions
- Articulate recent trends in DEA decisions and how this may affect your legal strategy
Gain access to this course, plus unlimited access to 1,800+ courses, with an Unlimited Subscription.Explore Lawline Subscriptions